HC Wainwright Has Optimistic Outlook of ACAD FY2027 Earnings
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – Equities researchers at HC Wainwright boosted their FY2027 EPS estimates for shares of ACADIA Pharmaceuticals in a research report issued to clients and investors on Monday, May 19th. HC Wainwright analyst A. Fein now anticipates that the biopharmaceutical company will earn $2.43 per share for the year, […]
